Lef1ΔN Binds β-Catenin and Increases Osteoblast Activity and Trabecular Bone Mass
Authors:
- Frank J. SecretoFSFrank J. Secreto
- David F. RazidloDRDavid F. Razidlo
- Tiffany J. WhitneyTWTiffany J. Whitney
- Jennifer J. WestendorfJWJennifer J. Westendorf
Open Access
- 1 April 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (13) , 10950-10959
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A role for YY1 in repression of dominant negative LEF-1 expression in colon cancerNucleic Acids Research, 2010
- Lef1 Haploinsufficient Mice Display a Low Turnover and Low Bone Mass Phenotype in a Gender- and Age-Specific MannerPLOS ONE, 2009
- Wnt signaling as a therapeutic target for bone diseasesExpert Opinion on Therapeutic Targets, 2009
- Where Wnts Went: The Exploding Field of Lrp5 and Lrp6 Signaling in BoneJournal of Bone and Mineral Research, 2009
- Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the DuodenumCell, 2008
- Building bone to reverse osteoporosis and repair fracturesJournal of Clinical Investigation, 2008
- Dominance of SOX9 function over RUNX2 during skeletogenesisProceedings of the National Academy of Sciences, 2006
- Diversity of LEF/TCF action in development and diseaseOncogene, 2006
- Wnt Activation and Alternative Promoter Repression of LEF1 in Colon CancerMolecular and Cellular Biology, 2006
- Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor ContextPLOS Biology, 2006